Illustration of SpaceOAR Hydrogel

SpaceOAR Vue Hydrogel

Radiopaque Perirectal Spacer for Radiation Therapy
Visibly Different video

Visibly Different

SpaceOAR Vue Hydrogel is the next-generation hydrogel spacer that offers enhanced visibility via CT scan


Get in touch with our team

Whether you're looking to get started with SpaceOAR Hydrogel or have general questions about the product, procedure or clinical data, our team is here to help.




SpaceOAR Vue Hydrogel in different image modalities.

T2-weighted Magnetic Resonance images*
T2-weighted Magnetic Resonance images*
Computed Tomography images*
Computed Tomography images*
kV Cone-beam Computed Tomography image (first fraction)*
kV Cone-beam Computed Tomography image (first fraction)*
kV Cone-beam Computed Tomography image (last fraction)
kV Cone-beam Computed Tomography image (last fraction)*




Hear clinicians discuss SpaceOAR Vue Hydrogel’s impact on their practice and their patients.


Dr. Ed Soffen
Ed Soffen, MD, a Radiation Oncologist, talks about the potential benefits of SpaceOAR Vue Hydrogel with easier contouring, better visibility and time-saving efficiency.
Dr. Daniel Peterit
Radiation Oncologist, Daniel Petereit, MD, discusses how SpaceOAR Vue Hydrogel is designed to be highly visible in a CT scan and may be beneficial for patients who cannot undergo an MRI.
Dr. Alaina Rizzo
Alaina Rizzo, a Radiation Therapist at Princeton Radiation Oncology, talks about how SpaceOAR Vue Hydrogel can help visualize the hydrogel under cone-beam CT to better manage patient alignment.
Dr. Joseph Hanley
Joseph Hanley, Ph.D., Director of Medical Physics at Princeton Radiation Oncology, discusses how SpaceOAR Vue Hydrogel had a positive impact on meeting dose-volume constraints of treatment plans.


Frequently Asked Questions

We've got the answers.


Get SpaceOAR Hydrogel

Become a certified applier.


Sign Up

Get exclusive updates and clincial data.




The benefits of SpaceOAR Vue Hydrogel

Radiopaque hydrogel allows visibility on CT scan
treatment planning can be done using CT only, reducing the need for MRI which may streamline workflow
CT visibility may hep reduce under-or over- contouring of the prostate and rectum for improved accuracy and optimized treatment planning
Radiopacity may provide a suitable imaging option to MRI for patients with implanted metallic devices allowing you to treat more patients



Real-world experience with SpaceOAR Vue Hydrogel

Dr. Elisha Fredman from the Davidoff Cancer Center and Rabin Medical Center in Petah Tikva, Israel shares his clinical experience with SpaceOAR Hydrogel Systems in his prostate cancer therapy approach.


Hear Dr. Fredman's conclusions >

View complete webinar on EDUCARE >



* Jeff Michalski, MD (2020). Permission granted by Washington University Imaging. 

1. Data on file with Boston Scientific

Caution: U.S. Federal law restricts this device to sale by or on the order of a physician.
CAUTION: The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings, and instructions for use can be found in the product labelling supplied with each device or at Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. This material not intended for use in France.
SpaceOAR and SpaceOAR Vue Hydrogels are intended to temporarily position the anterior rectal wall away from the prostate during radiotherapy for prostate cancer and in creating this space it is the intent of SpaceOAR and SpaceOAR Vue Hydrogels to reduce the radiation dose delivered to the anterior rectum.
SpaceOAR and SpaceOAR Vue Hydrogels contain polyethylene glycol (PEG). SpaceOAR Vue Hydrogel contains iodine.
Prior to using these devices, please review the Instructions for Use for a complete listing of indications, contraindications, warnings, precautions and potential adverse events.
As with any medical treatment, there are some risks involved with the use of SpaceOAR and SpaceOAR Vue Hydrogels. Potential complications associated with SpaceOAR and SpaceOAR Vue Hydrogels include, but are not limited to: pain associated with SpaceOAR and SpaceOAR Vue Hydrogels injection, pain or discomfort associated with SpaceOAR and SpaceOAR Vue Hydrogels, local inflammatory reactions, infection (including abscess), urinary retention, urgency, constipation (acute, chronic, or secondary to outlet perforation), rectal tenesmus/muscle spasm, mucosal damage, ulcers, fistula, perforation (including prostate, bladder, urethra, rectum), necrosis, allergic reaction (localized or more severe reaction, such as anaphylaxis), embolism (venous or arterial embolism is possible and may present outside of the pelvis, potentially impacting vital organs or extremities), syncope and bleeding. The occurrence of one or more of these complications may require treatment or surgical intervention. URO-989811-AB.
All images are the property of Boston Scientific. All trademarks are the property of their respective owners.